NCT01471405 One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma Status COMPLETED Phase N/A
NCT01412424 Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly Status COMPLETED Phase PHASE3
NCT01371045 Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs Status WITHDRAWN Phase N/A
NCT01368133 The Observational Study of Growth Hormone-secreting Pituitary Tumors Status UNKNOWN Phase N/A
NCT01333384 Study in Polish Acromegalic Patients Treated With Somatuline Autogel Status COMPLETED Phase N/A
NCT01302652 Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment Status COMPLETED Phase N/A
NCT01295060 Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly Status TERMINATED Phase PHASE3
NCT01278342 Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients Status COMPLETED Phase PHASE4
NCT01265121 Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism. Status UNKNOWN Phase NA
NCT01137682 Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly Status COMPLETED Phase PHASE3
NCT01086982 Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ® Status SUSPENDED Phase PHASE1
NCT01029275 Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone Status COMPLETED Phase NA
NCT01014793 Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients Status COMPLETED Phase N/A
NCT00994214 Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly Status TERMINATED Phase PHASE2